BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8981097)

  • 41. Fundamentals are still relevant in toxicology.
    Eaton DL; Greenlee WF
    Nature; 2002 May; 417(6885):117. PubMed ID: 12000934
    [No Abstract]   [Full Text] [Related]  

  • 42. On the use of in silico tools for prioritising toxicity testing of the low-volume industrial chemicals in REACH.
    Rybacka A; Rudén C; Andersson PL
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):77-87. PubMed ID: 24428755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.
    Blaauboer BJ; Boekelheide K; Clewell HJ; Daneshian M; Dingemans MM; Goldberg AM; Heneweer M; Jaworska J; Kramer NI; Leist M; Seibert H; Testai E; Vandebriel RJ; Yager JD; Zurlo J
    ALTEX; 2012; 29(4):411-25. PubMed ID: 23138511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
    Péry AR; Desmots S; Mombelli E
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of professional judgment in chemical hazard assessment and communication.
    Hamilton JD; Daggett DA; Pittinger CA
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):84-92. PubMed ID: 16843576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tox21 to date: steps toward modernizing human hazard characterization.
    Betts KS
    Environ Health Perspect; 2013 Jul; 121(7):A228. PubMed ID: 23816934
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter to the editor (Wright-Walters et al., 2011).
    Hentges S; Caspers N; Klecka GM; Mihaich EM; Ortego L; Staples CA
    Sci Total Environ; 2013 Apr; 450-451():369-71. PubMed ID: 22704005
    [No Abstract]   [Full Text] [Related]  

  • 50. The EU REACH system: opportunities and threats.
    Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():1-4. PubMed ID: 16555954
    [No Abstract]   [Full Text] [Related]  

  • 51. [Assessment of the relationship of properties of chemical compounds and their toxicity to a unified hygienic standardization for chemicals].
    Trushkov VF; Perminov KA; Sapozhnikova VV; Ignatova OL
    Gig Sanit; 2013; (2):87-90. PubMed ID: 24003710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathways of Toxicity.
    Kleensang A; Maertens A; Rosenberg M; Fitzpatrick S; Lamb J; Auerbach S; Brennan R; Crofton KM; Gordon B; Fornace AJ; Gaido K; Gerhold D; Haw R; Henney A; Ma'ayan A; McBride M; Monti S; Ochs MF; Pandey A; Sharan R; Stierum R; Tugendreich S; Willett C; Wittwehr C; Xia J; Patton GW; Arvidson K; Bouhifd M; Hogberg HT; Luechtefeld T; Smirnova L; Zhao L; Adeleye Y; Kanehisa M; Carmichael P; Andersen ME; Hartung T
    ALTEX; 2014; 31(1):53-61. PubMed ID: 24127042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1.2 Aspects of test assessment.
    Hoffmann S
    Hum Exp Toxicol; 2009 Feb; 28(2-3):95-6. PubMed ID: 19713368
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel method to prevent secondary exposure of medical and rescue personnel to toxic materials under biochemical hazard conditions using microwave radar and infrared thermography.
    Matsui T; Hagisawa K; Ishizuka T; Takase B; Ishihara M; Kikuchi M
    IEEE Trans Biomed Eng; 2004 Dec; 51(12):2184-8. PubMed ID: 15605866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The future of toxicology--wrap up.
    Jacobs AT; Marnett LJ
    Chem Res Toxicol; 2007 Jul; 20(7):983-5. PubMed ID: 17630814
    [No Abstract]   [Full Text] [Related]  

  • 56. Toxicity assessment of unintentional exposure to multiple chemicals.
    Mumtaz MM; Ruiz P; De Rosa CT
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):104-13. PubMed ID: 17599373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Learning from Sisyphus: time to rethink our current, ineffective strategy on neurodevelopmental environmental toxicants.
    Takser L; Hunting DJ
    Environ Health; 2020 Mar; 19(1):31. PubMed ID: 32160895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evidence-based toxicological evaluation of chemicals by group summaries].
    Greim H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1417-25. PubMed ID: 19137217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation of the basic hazard index screening for health risks associated with simultaneous exposure to multiple chemicals using a standardized target organ and systems framework.
    Adams VH; McAtee MJ; Johnson MS
    Integr Environ Assess Manag; 2017 Sep; 13(5):852-860. PubMed ID: 28135038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.